AP306 125 mg BID

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AP306 125 mg BID
Treatment and conditionWhere it standsTrials
AP306 125 mg BID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1